Valeritas (VLRXQ) Stock Price, News & Analysis

Company Overview

Valeritas Holdings, Inc., a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States. The company offers V-Go, a wearable insulin delivery device for basal-bolus therapy. It also develops V-Go Prefill that is in the design-development stage for eliminating the device-filling process and the need for EZ fill refrigeration for patients with Type 2 diabetes; and V-Go SIM for real-time tracking information of basal and bolus dosing utilization. The company sells V-Go to third-party wholesalers and medical supply distributors. Valeritas Holdings, Inc. was founded in 2006 and is headquartered in Bridgewater, New Jersey.

Key Stats

• Today's Range: $0.02 to $0.02
• 50-Day Range: $0.02 to $0.02
• 52-Week Range: $0.01 to $4.28
• Volume: N/A
• Average Volume: 231,257 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

VLRXQ Stock Analysis - Frequently Asked Questions

How have VLRXQ shares performed this year?

Valeritas' stock was trading at $0.02 on January 1st, 2024. Since then, VLRXQ shares have increased by 0.0% and is now trading at $0.02.
View the best growth stocks for 2024 here.

How were Valeritas' earnings last quarter?

Valeritas Holdings, Inc. (OTCMKTS:VLRXQ) announced its earnings results on Tuesday, November, 12th. The company reported ($1.91) EPS for the quarter, topping analysts' consensus estimates of ($2.52) by $0.61. The company earned $8.46 million during the quarter.

How do I buy shares of Valeritas?

Shares of VLRXQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Last Earnings: 11/12/2019
• Today: 11/26/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:VLRXQ
• CUSIP: N/A
• CIK: 1619250
• Web: www.valeritas.com
• Phone: 908-927-9920
• Fax: 908-927-9927
• Employees: 125
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A